Full Service CRO DSP Clinical Research Triples Revenue in 2010
Achievements include Completing Enrollment for Major Phase 3 Study Three Months Early; DSP President Darlene Panzitta Recognized by Ernst & Young; DSP Soars on Inc. 500/5000 List for Third Consecutive Year
PARSIPPANY, NJ, February 15, 2011 – DSP Clinical Researchannounced record-breaking growth in 2010, tripling its revenue and expanding its staff by 45%. DSP is a nationally-recognized, full service CRO that provides customer-focused, results-driven CRO services for small to mid-size pharmaceutical and biotechnology companies conducting Phase 1-4 clinical studies. DSP delivers the highest quality data with innovative, flexible services; a unique fixed-cost billing model; and hands-on customer service.
New and existing customers chose DSP to manage clinical trials in a range of therapeutic areas including its specialties in women’s health, pediatrics, pain and urology.
2010 highlights included DSP’s completion of enrollment three months ahead of schedule for a large Phase 3 study in women’s health. (DSP is managing the entire study process through NDA submission.)
DSP President and Founder Darlene Panzitta said, “In 2011 DSP will continue to redefine the CRO industry and establish our market dominance as the CRO that’s one step ahead in meeting customer expectations.”
Additional 2010 key achievements included:
National Awards – For the third consecutive year DSP was named to the Inc. 500/5000 list of the fastest growing private companies in the U.S. Additionally, Darlene Panzitta was one of only 11 executives nationwide to win the prestigious Ernst & Young LLP’s 2010 Entrepreneurial Winning Women™ award.
Corporate Development – DSP promoted senior executive Brenda Reese, BSN, RN, CCRA, to Vice President of Business Operations. Ms. Reese, who has been in the pharmaceutical industry for 16 years, offers sponsors a valuable blend of clinical and business expertise. DSP increased its staff by 45% and opened 10 job requisitions including a director of business development to continue innovating and improving customer service.
Thought Leadership – DSP was invited to share insights and advice in bylined articles for prestigious publications such ACRP’s The Monitor and Applied Clinical Trials magazines. DSP executives also were invited to speak at industry events on vital topics such as avoiding changes of scope and the steps to becoming a successful CRO monitor.
About DSP Clinical Research
DSP is a full service CRO that manages Phase 1-4 clinical studies for small to mid-sized pharmaceutical, biotech, and device companies from study set up through FDA submission. DSP helps clients get drugs to market faster than their competition with an aggressive management style and use of a fixed-cost billing model. Services include study management, site monitoring, investigator site management, data management, biostatistics, study rescue, site and monitor training/auditing, medical writing, and FDA submissions. Services are flexible and DSP provides an à la carte approach to complement clients’ clinical experience, resources, and staff. DSP is headquartered in Parsippany, NJ. For more information please visit www.www.dspclinical.com. Follow DSP Clinical Research on Facebook and Twitter.
Contact: Brenda Nashawaty, Nashawaty Communications, firstname.lastname@example.org, 617-688-3253